Back to Search
Start Over
Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study
- Source :
- The Lancet Psychiatry; October 2015, Vol. 2 Issue: 10 p901-908, 8p
- Publication Year :
- 2015
-
Abstract
- Opioid dependence increases risk of premature mortality. Opioid substitution therapy with methadone or buprenorphine reduces mortality risk, especially for drug-related overdose. Clinical guidelines recommend methadone as the first line of opioid substitution therapy. We aimed to test whether buprenorphine treatment has a lower mortality risk than does methadone treatment by comparing all-cause mortality and drug-related overdose mortality at treatment induction, after in-treatment medication switches, and following treatment cessation.
Details
- Language :
- English
- ISSN :
- 22150366
- Volume :
- 2
- Issue :
- 10
- Database :
- Supplemental Index
- Journal :
- The Lancet Psychiatry
- Publication Type :
- Periodical
- Accession number :
- ejs36800297
- Full Text :
- https://doi.org/10.1016/S2215-0366(15)00366-1